Date
24 May 2023
Pollution from antibiotic factories highlighted as public health risk
John Reed, writing for the Financial Times on pollution from the manufacture of antibiotics, spoke to Fatema Rafiqi, our Research Programme Manager for antimicrobial resistance (AMR).
Direct links
The article looks at India's position as both a large producer and consumer of antibiotics (they can be purchased over the counter with little guidance), and how this puts it at the centre of concerns over AMR.
Fatema is quoted, on the investment of time and money needed by antibiotic manufacturers to produce a new antibiotic, and how this is being disincentivised by the impact of AMR.
Read the article on the Financial Times website.